R&D | February 04, 2026
Epigenica launches EpiFinder Analysis Service to accelerate Epigenomic research
The new service delivers end-to-end support, managing every stage of an epigenomics project
The new service delivers end-to-end support, managing every stage of an epigenomics project
The new functionality complements Parse’s existing Evercode immune products
The randomized, double-blind, placebo-controlled Phase 2b VITAL trial enrolled 91 patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer
The partnership aims to fuse Avantium’s breakthrough materials with Packamama’s expertise in low-emission, innovative wine bottles
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Groundbreaking collaboration harnesses AI-driven insights and advanced manufacturing to create next-generation adjuvants for emerging biological threats
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Subscribe To Our Newsletter & Stay Updated
